A Guideline To Lipid Lowering AgentsTreatment guidelines for lowering cholesterol levels have recently been updated and recommendations for multi-drug regimens have decreased. In long-term care [...]
What You Need to Know About Duragesic (Fentanyl)Fentanyl (Duragesic) patches are often used in the long-term care setting for residents requiring around-the-clock pain management. Over the past [...]
Update on Repatha (Evolocumab) - a Medication Used to Treat High Low Density Lipoprotein CholesterolApproved by the FDA in August 2015, Repatha (Evolocumab) is a subcutaneous injection used to [...]
FDA Recommends Restricting the Use of Fluoroquinolones Due to Potential Side EffectsThe FDA has recently released a statement indicating that the use of systemic fluoroquinolones should be [...]
AlixaRx Makes Enhancements to Therapeutic Interchange ProgramAlixaRx is pleased to announce that we have expanded our Therapeutic Interchange (TI) program. This program allows prescribers to [...]
Xarelto ® in Long-Term CareFor decades warfarin (Coumadin) was the only available oral anticoagulant on the market. Its use is complicated by a long list of drug interactions and requirements [...]
Cleaning Glucometers Appropriate cleaning or disinfecting of glucometers in long-term care facilities is cited in the CMS State Operations Manual under F-Tag 441 infection control guidelines. [...]
Proton-Pump Inhibitors (PPIs) in Long-term Care Late last year, we reported on mounting evidence of adverse drug events associated with PPIs: Drug Interactions PPIs are implicated in a number of [...]
Vitamin K in Long-Term Care Background A skilled-stay rehab patient on Coumadin recently had a supratherapeutic INR of 5.2. The patient had no evidence of abnormal bleeding. The provider was [...]
Figure 1. What’s wrong with this insulin pen in Figure 1? The large air bubble at the top is an indicator that the cartridge was incorrectly used as a vial to withdraw insulin. Insulin pen [...]